Skip to content
Facebook page opens in new windowTwitter page opens in new windowInstagram page opens in new windowLinkedin page opens in new window
Upcoming ActivitiesBecome a Member
GCC AIR
GCC Association of Immunology & Rheumatology
GCC AIR
  • ABOUT US
    • ABOUT
      • About GCC AIR
      • Contact Us
    • GOVERNANCE
      • Board of Directors
      • Advisory Committee
      • Standing Committee
      • Specialty Committee
    • COMMITTEE
      • Research Experts
      • Guest Counselors
      • Women’s Rheumatology Alliance
    • Editorial Board
  • EVENTS & EDUCATION
    • Learning Center
      • Online Education
      • CME Certificates
    • Webinar
      • Past Webinars
    • Activities
      • MRC 2025
      • Past Activities
    • CERTIFICATION
      • CRISP (ACRP certification of attendance)
    • Publication
      • Saudi Medical Journal
  • MEDIA
  • COLLABORATORS
  • MEMBERSHIP
    • Membership Directory
    • Become a GCC AIR Member
  • LOGIN
  • ABOUT US
    • ABOUT
      • About GCC AIR
      • Contact Us
    • GOVERNANCE
      • Board of Directors
      • Advisory Committee
      • Standing Committee
      • Specialty Committee
    • COMMITTEE
      • Research Experts
      • Guest Counselors
      • Women’s Rheumatology Alliance
    • Editorial Board
  • EVENTS & EDUCATION
    • Learning Center
      • Online Education
      • CME Certificates
    • Webinar
      • Past Webinars
    • Activities
      • MRC 2025
      • Past Activities
    • CERTIFICATION
      • CRISP (ACRP certification of attendance)
    • Publication
      • Saudi Medical Journal
  • MEDIA
  • COLLABORATORS
  • MEMBERSHIP
    • Membership Directory
    • Become a GCC AIR Member
  • LOGIN

Long-term Efficacy and Safety of Upadacitinib in Patients With Psoriatic Arthritis Refractory to Biologic Therapies: 2-Year Results From the Phase 3 SELECT-PsA 2 Study

2022, Abstract, Clinical Research, GCC AIR Annual CongressBy sara12/12/2022

Chicago, United States of America

Go to Top